cGxP.wire https://validator.w3.org/feed/docs/rss2.html Jazz Presents New Xywav Data at SLEEP 2026 Meeting Zai Lab Secures EMA Support for Rare Lung Cancer Therapy AccurKardia’s AK-AVS Joins FDA TAP Program for AI Heart Screening Niowave and Ratio Partner to Advance Actinium-225 Supply Innoviva and Dr. Reddy’s Expand Global Access to XACDURO® Intelligent Bio Solutions Expands Clinical Validation of Fingerprint Drug Screening Technology FibroBiologics Doses First Patients in Phase 1/2 Trial of CYWC628 for Diabetic Foot Ulcers Quoin Advances QRX003 Development with Positive Pediatric Netherton Syndrome Update Akston’s AKS-699 Demonstrates One-Year Pruritus Control with Fewer Treatments Nexalin Technology Highlights Positive Anxiety and Insomnia Data at NYC Neuromodulation Conference 2026 SonoClear Study Selected for EANS 2026 Oral Presentation NeOnc Expands International Clinical Development of NEO212 for Glioblastoma Nervonik Completes First Human Nerve Sensing Study Edgewise Reports Positive Phase 2 EDG-7500 HCM Data Guided Therapeutics Advances FDA Review of LuViva Cervical Cancer Screening Technology Castle TissueCypher Surpasses 100,000 Orders in Barrett’s Optimi Health Launches Standardized Psilocybin Microdose Capsules for Clinical Research Fujifilm and HORIBA Achieve 10% Antibody Yield Improvement with New Raman Technology FDA Approves Allergan’s SKINVIVE by JUVÉDERM for Neck Line Reduction Takeda Oveporexton Shows Broad Benefits in Narcolepsy SurGenTec Gains FDA Clearance for ION-L Spine System Gilead’s Once-Weekly Yeztugo Accepted by FDA for HIV Prevention Review Qihan Biotech’s QT-019B Earns FDA RMAT and Breakthrough Therapy Designations Halia Therapeutics Secures FDA Fast Track for Ofirnoflast BioMarin Reports Positive VOXZOGO and BMN 333 Data at ENDO 2026 AMDI Wins FDA Approval for Sub-10-Minute Respiratory PCR Test Halozyme Reaffirms Long-Term Royalty Growth Despite Proposed Medicare Pricing Changes Nabsys and LUMC Advance FSHD Research With Genome Mapping Neurocrine’s CRENESSITY Delivers Two-Year Cardiometabolic Benefits in Adult CAH Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth Harbour BioMed and BioMap Unveil AI-Powered MegaStream TechBio Platform Elanco Wins USDA Approval for TruCan Ultra Lyme-L4 Vaccine SK Life Science NDA for Cenobamate Suspension Accepted Inhibrx Wins FDA BLA Acceptance for Ozekibart in Chondrosarcoma Akeso Enrolls First Patient in AK138D1-Ivonescimab Breast Cancer Trial Bambusa Therapeutics Reports Positive Phase 1 BBT002 Data at EAACI 2026 IDEAYA Launches Phase 1/2 Study of IDE892 in MTAP-Deleted Cancers TuHURA Files IND for TBS-2025 in AML and Blood Cancers Neurocrine Reports Two-Year CRENESSITY Data Showing Improved Growth in Pediatric CAH FDA Approves KEYTRUDA-WELIREG Combination for High-Risk Kidney Cancer Patients FDA Authorizes First Generic Treatment for New World Screwworm Lilly’s Jaypirca Reduces Risk of Disease Progression or Death by 45% in CLL/SLL AstraZeneca’s Truqap Becomes First Targeted Therapy Approved for PTEN-Deficient Prostate Cancer FDA Clears Dexcom Stelo OTC CGM for Children Menarini Reports Positive Phase 3 SENTRY Data at EHA Gan & Lee Showcases Metabolic Pipeline Data at ADA 2026 Lateral Pharma Strengthens Pain Therapeutics Pipeline with LANCL1 Discovery Roche Advances Precision Oncology with PTEN Diagnostic Approval Johnson & Johnson Reveals Promising Phase 3 Results for Bispecific Myeloma Therapy Lyell Immunopharma Showcases Updated Ronde-Cel Data at EHA 2026